norfloxacin has been researched along with ro13-9904 in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (60.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rahal, K | 1 |
| Gill, CJ; Ponticas, S; Shungu, DL | 1 |
| Auckenthaler, R; Marchou, B; Michéa-Hamzehpour, M; Pechère, JC | 2 |
| Martin, E; Nauciel, C | 1 |
| Berardi-Grassias, L; Bigel, ML; Boisivon, A; Chauvière, P; Guiomar, C; Macheboeuf, F | 1 |
| Balanzó, J; Guarner, C; Kolle, L; Novella, MT; Ortiz, J; Pamplona, J; Sàbat, M; Sainz, S; Soriano, G; Torras, J; Villanueva, C | 1 |
| Arroyo, V; Durandez, R; Fernández, J; Gómez, C; Guarner, C; Navasa, M; Planas, R; Ruiz del Arbol, L; Serradilla, R | 1 |
| Bert, F; Bourdon, N; Le Grand, J; Leflon-Guibout, V; Nicolas-Chanoine, MH | 1 |
| Chongsuvivatwong, V; McNeil, E; Sangthong, R; Tang, R; Xu, J | 1 |
1 review(s) available for norfloxacin and ro13-9904
| Article | Year |
|---|---|
[Emergence of vancomycin-dependent enterococci following glycopeptide therapy: case report and review].
Topics: Bacterial Proteins; Bacteriuria; Carbon-Oxygen Ligases; Cecal Diseases; Ceftriaxone; Citrobacter freundii; Codon, Nonsense; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Electrophoresis, Gel, Pulsed-Field; Enterobacteriaceae Infections; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Intestinal Perforation; Liver Transplantation; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Norfloxacin; Peritonitis; Postoperative Complications; Staphylococcal Infections; Teicoplanin; Vancomycin; Vancomycin Resistance | 2009 |
2 trial(s) available for norfloxacin and ro13-9904
| Article | Year |
|---|---|
Parenteral antibiotic prophylaxis of bacterial infections does not improve cost-efficacy of oral norfloxacin in cirrhotic patients with gastrointestinal bleeding.
Topics: Administration, Oral; Aged; Anti-Infective Agents; Bacterial Infections; Ceftriaxone; Cephalosporins; Cost-Benefit Analysis; Female; Gastrointestinal Hemorrhage; Humans; Incidence; Injections, Intravenous; Liver Cirrhosis; Male; Middle Aged; Norfloxacin | 1998 |
Norfloxacin vs ceftriaxone in the prophylaxis of infections in patients with advanced cirrhosis and hemorrhage.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotic Prophylaxis; Bacteremia; Bacterial Infections; Ceftriaxone; Female; Gastrointestinal Hemorrhage; Humans; Injections, Intravenous; Liver Cirrhosis; Male; Middle Aged; Norfloxacin; Peritonitis; Risk Factors; Treatment Outcome | 2006 |
7 other study(ies) available for norfloxacin and ro13-9904
| Article | Year |
|---|---|
[Activity of cefotaxime and ceftriaxone and of imipenem, pefloxacin and norfloxacin on 13 species of bacteria].
Topics: Bacteria; Cefotaxime; Ceftriaxone; Drug Resistance, Microbial; Imipenem; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin; Species Specificity | 1989 |
Comparative in vitro activity of norfloxacin against resistant Neisseria gonorrhoeae.
Topics: Ceftizoxime; Ceftriaxone; Drug Resistance, Microbial; Humans; Neisseria gonorrhoeae; Norfloxacin; Penicillin Resistance; Penicillinase; Penicillins; Spectinomycin; Tetracycline; Tetracycline Resistance | 1989 |
Emergence of resistance after therapy with antibiotics used alone or combined in a murine model.
Topics: Amikacin; Animals; Bacteria; Bacterial Infections; Ceftriaxone; Drug Resistance, Microbial; Drug Therapy, Combination; Enterobacter; Escherichia coli; Female; Kanamycin; Klebsiella pneumoniae; Mice; Norfloxacin; Pefloxacin; Peritonitis; Pseudomonas aeruginosa; Serratia marcescens; Staphylococcus aureus | 1986 |
Combination therapy: a way to limit emergence of resistance?
Topics: Amikacin; Animals; Anti-Bacterial Agents; Ceftriaxone; Drug Resistance, Microbial; Drug Therapy, Combination; Enterobacter; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Female; Klebsiella Infections; Klebsiella pneumoniae; Mice; Mice, Inbred ICR; Norfloxacin; Pefloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Serratia marcescens; Staphylococcal Infections; Staphylococcus aureus; Time Factors | 1986 |
[Comparative efficacy of ampicillin, chloramphenicol, cefotaxime, ceftriaxone and pefloxacin in experimental Salmonella typhimurium infection].
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Cefotaxime; Ceftriaxone; Chloramphenicol; Female; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Norfloxacin; Pefloxacin; Salmonella Infections, Animal; Salmonella typhimurium | 1987 |
[In vitro study of the pefloxacine-ceftriaxone combination against 18 strains of Acinetobacter].
Topics: Acinetobacter; Ceftriaxone; Drug Combinations; Drug Synergism; In Vitro Techniques; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin; Time Factors | 1986 |
Antibiotic use in chicken farms in northwestern China.
Topics: Adult; Animals; Anti-Bacterial Agents; Ceftriaxone; Chickens; China; Cross-Sectional Studies; Drug Misuse; Farms; Female; Health Knowledge, Attitudes, Practice; Health Policy; Humans; Logistic Models; Male; Middle Aged; Norfloxacin; Ofloxacin; One Health; Oxytetracycline; Socioeconomic Factors; Surveys and Questionnaires; Young Adult | 2020 |